Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Contact

1 result

  • Active substance : romiplostim
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Health economics (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Drug therapy (1)
  • Diseases and conditions (1)
  • Plus ...
    • Congenital, genetic and rare diseases (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Blood coagulation and hemostasis disorders (1)
      • Bone marrow diseases (1)
    • Immune system diseases (1)
    • Plus ...
      • Autoimmune diseases (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Medicine (1)
Date
  • Last five years (1)
Language
  • Français (1)
Active substance
  • romiplostim (1)

Drugs, devices and medical acts - 1 result

  • NPLATE

    Medicine - Posted on 20/10/2021
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
KYZ9cGnmQazsR8mt